Category: News

Christina Mark — PhD and Artist

Christina (aka Tina) Mark, a cancer biology graduate student, recently defended her thesis and is currently looking for scientist positions in the Boston area to continue her love of asking questions and designing experiments.  Outside of her scientific endeavors, Tina has also showcased her accomplishments as an artist. Tina grew up on the east coast, …

Miyamoto Named Vilas Distinguished Achievement Professor

The University of Wisconsin–Madison recently announced that McArdle Professor Shigeki Miyamoto has been selected to receive a 2022-23 Vilas Distinguished Achievement Professorship. This award, named in honor of U.S. Senator and UW Regent William F. Vilas (1840-1908), recognizes “distinguished scholarship as well as standout efforts in teaching and service”.  The award provides 5 years of …

Loke and Snow Receive 2022 Elegbede Cancer Research Award

Amanda Loke and Santina Snow have been selected as the 2022 recipients of the the Dr. J. Abiodun Elegbede Cancer Research Award. This award, administered by the McArdle Laboratory for Cancer Research, was established through the generosity of the Elegbede family in honor of the late Dr. J. Abiodum Elegbede, who conducted postdoctoral research in …

Dr. Nathan Sherer Awarded H.I. Romnes Faculty Fellowship

In recognition of his stellar academic success, McArdle faculty member Nathan Sherer has been named a 2022 H.I. Romnes Faculty Fellow.  This award provides flexible research funding over the next five years for the continued development of Dr. Sherer’s outstanding research program. Dr. Sherer, Associate Professor of Oncology and Molecular Virology, studies the cell biology underpinning …

Student Profile: Sean Kraus

Student Profile Sean Kraus (Dusty Deming laboratory) Where are you from? Why Madison and the Cancer Biology program? I am from Hannibal, MO, but my entire family is from Minnesota. I applied to UW’s Cancer Bio program because one of my undergraduate lab mentors got his undergraduate degree at UW, and my Cancer Biology Capstone …

Student Profile: Donna Li

Student Profile: Donna Li (Miyamoto Lab) Where are you from? Why Madison and the Cancer Biology program? I am originally from East Los Angeles, California and chose to come to Madison to escape the yearly wildfires and oppressive traffic—but I also knew that I would be happy here and grow as a scientist. I applied …

Professor Shannon Kenney receives prestigious Henle Award, recognizing impactful contributions to research on Epstein-Barr virus

Professor Shannon Kenney receives prestigious Henle Award, recognizing impactful contributions to research on Epstein-Barr virus. The McArdle Laboratory congratulates Professor Shannon Kenney on her selection to receive the 2022 Henle Award from the International Association for Research on Epstein-Barr Virus and Associated Diseases. The Henle Award recognizes Dr. Kenney’s consistent, impactful, and world-renowned contributions to our understanding …

McArdle & Women’s History Month

March is Women’s History Month.  It is a time to reflect on the accomplishments of women of previous generations and to celebrate the impact they have had on our lives. There were three women who joined the McArdle Laboratory in its very early years and who spent their entire careers here.  With over 125 years …

The Spirit of Innovation: Leading the Way in Cancer Virology

It’s estimated that roughly 15-20 percent of cancers are associated, in some way, with a virus. Whether it’s Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV) or Hepatitis C – just to name a few – viruses and cancer frequently go hand-in-hand. Fortunately, virology researchers at the University of Wisconsin have been studying the virus/cancer relationship …

Breast Cancer Researchers Learn How to Teach an Old Drug New Tricks to Help Patients

Paclitaxel, or Taxol, is an old standby drug in the oncologist’s tool belt. Yet only about half of breast cancer patients treated with the drug see their tumors shrink or disappear, and doctors and researchers have no way of knowing which patients will benefit. But that may soon change.